{
    "info": {
        "nct_id": "NCT06616766",
        "official_title": "A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion",
        "inclusion_criteria": "* ECOG performance status 0 or 1\n* Estimated life expectancy of at least 3 months\n* Patients who have progressed on or after all available standard therapies or for whom standard treatment is inappropriate\n* Mandatory provision of archived or fresh tumor tissue in quantity sufficient to allow for retrospective confirmation of HER2 or EGFR mutation\n* A patient with a history of brain metastases must have had all lesions treated\n* Adequate organ function defined as all of the following:\n\n  * Adequate bone marrow function (within 1 week prior to first administration): Neutrophils≥1.5 x10*9 cells/L (Criteria must be met without the use of Granulocyte-Colony Stimulating Factor (G-CSF) within last week prior to testing.); platelet count≥75 x10*9 cells/L; Hb ≥9g/dL (Criteria must be met without packed red blood cell (pRBC) transfusion within last week prior to testing.)\n  * Adequate hepatic function: Serum bilirubin≤1.5 x upper limit of normal (ULN), and serum transaminase (either aspartate transaminase (AST) or alanine transaminase (ALT)) ≤ 3 x ULN if no demonstrable liver metastases, or otherwise ≤ 5 x ULN if transaminase elevation is attributable to liver metastases (within 1 week prior to first administration)\n  * Adequate renal function: Serum creatinine ≤ 1.5 x ULN or Estimated glomerular filtration rate (eGFR) > 60 mL/min per 1.73 m*2 according to the site's calculation method.\n\n[Dose Escalation part only]\n\n* Histologically or cytologically confirmed diagnosis of advanced, and/or metastatic non-hematologic malignancy\n* Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)\n\n[Dose Expansion part only]\n\n* Patients with histologically or cytologically confirmed locally advanced or metastatic NSCLC HER2 exon 20 insertion (Cohort 1)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Patient with symptomatic or progressive brain metastases\n* Known or suspected leptomeningeal disease (LMD)\n* Uncontrolled spinal cord compression\n* History of acute coronary syndromes, including myocardial infarction, coronary artery bypass graft, unstable angina, coronary angioplasty or stenting within past 24 weeks\n* History of or current Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system\n* Medical, psychiatric, cognitive or other conditions that compromise the patients ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study\n* Any severe concurrent disease or condition (includes active infections, cardiac arrhythmia) that in the judgment of the Investigator would make study participation inappropriate for the patient\n* History of (non-infectious) interstitial lung disease (ILD) or pneumonitis that required steroids, or any evidence of current ILD or pneumonitis\n* History of a second primary cancer with the exception of\n\n  1. curatively treated non-melanomatous skin cancer,\n  2. curatively treated cervical or breast carcinoma in situ, or\n  3. other malignancy with no known active disease present and no treatment administered during the last 2 years\n* Infection with human immunodeficiency virus (HIV) or prior hepatitis B or active chronic hepatitis B or active hepatitis C\n* Major surgery within 4 weeks prior to the first dose of study treatment",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Histologically or cytologically confirmed diagnosis of advanced, and/or metastatic non-hematologic malignancy",
            "criterions": [
                {
                    "exact_snippets": "Histologically or cytologically confirmed diagnosis",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "diagnosis of advanced, and/or metastatic non-hematologic malignancy",
                    "criterion": "malignancy type and stage",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "non-hematologic malignancy"
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Mandatory provision of archived or fresh tumor tissue in quantity sufficient to allow for retrospective confirmation of HER2 or EGFR mutation",
            "criterions": [
                {
                    "exact_snippets": "Mandatory provision of archived or fresh tumor tissue in quantity sufficient",
                    "criterion": "tumor tissue",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": "sufficient"
                        }
                    ]
                },
                {
                    "exact_snippets": "retrospective confirmation of HER2 or EGFR mutation",
                    "criterion": "HER2 or EGFR mutation",
                    "requirements": [
                        {
                            "requirement_type": "confirmability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate organ function defined as all of the following:",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients who have progressed on or after all available standard therapies or for whom standard treatment is inappropriate",
            "criterions": [
                {
                    "exact_snippets": "Patients who have progressed on or after all available standard therapies",
                    "criterion": "progression on standard therapies",
                    "requirements": [
                        {
                            "requirement_type": "progression_status",
                            "expected_value": "progressed"
                        }
                    ]
                },
                {
                    "exact_snippets": "for whom standard treatment is inappropriate",
                    "criterion": "appropriateness of standard treatment",
                    "requirements": [
                        {
                            "requirement_type": "appropriateness",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "[Dose Expansion part only]",
            "criterions": [
                {
                    "exact_snippets": "Dose Expansion part only",
                    "criterion": "trial part",
                    "requirements": [
                        {
                            "requirement_type": "participation",
                            "expected_value": "Dose Expansion part only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "[Dose Escalation part only]",
            "criterions": [
                {
                    "exact_snippets": "Dose Escalation part only",
                    "criterion": "trial phase",
                    "requirements": [
                        {
                            "requirement_type": "participation",
                            "expected_value": "Dose Escalation part only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Estimated life expectancy of at least 3 months",
            "criterions": [
                {
                    "exact_snippets": "Estimated life expectancy of at least 3 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A patient with a history of brain metastases must have had all lesions treated",
            "criterions": [
                {
                    "exact_snippets": "A patient with a history of brain metastases",
                    "criterion": "history of brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must have had all lesions treated",
                    "criterion": "brain metastases lesions",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "all lesions treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate renal function: Serum creatinine ≤ 1.5 x ULN or Estimated glomerular filtration rate (eGFR) > 60 mL/min per 1.73 m*2 according to the site's calculation method.",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine ≤ 1.5 x ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Estimated glomerular filtration rate (eGFR) > 60 mL/min per 1.73 m*2",
                    "criterion": "estimated glomerular filtration rate (eGFR)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 60,
                                "unit": "mL/min per 1.73 m*2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with histologically or cytologically confirmed locally advanced or metastatic NSCLC HER2 exon 20 insertion (Cohort 1)",
            "criterions": [
                {
                    "exact_snippets": "histologically or cytologically confirmed",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "histology",
                                "cytology"
                            ]
                        },
                        {
                            "requirement_type": "confirmation_status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic NSCLC",
                    "criterion": "NSCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "HER2 exon 20 insertion",
                    "criterion": "HER2 exon 20 insertion mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hepatic function: Serum bilirubin≤1.5 x upper limit of normal (ULN), and serum transaminase (either aspartate transaminase (AST) or alanine transaminase (ALT)) ≤ 3 x ULN if no demonstrable liver metastases, or otherwise ≤ 5 x ULN if transaminase elevation is attributable to liver metastases (within 1 week prior to first administration)",
            "criterions": [
                {
                    "exact_snippets": "Serum bilirubin≤1.5 x upper limit of normal (ULN)",
                    "criterion": "serum bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "serum transaminase (either aspartate transaminase (AST) or alanine transaminase (ALT)) ≤ 3 x ULN if no demonstrable liver metastases",
                    "criterion": "serum transaminase (AST or ALT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        },
                        {
                            "requirement_type": "liver metastases",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "serum transaminase (either aspartate transaminase (AST) or alanine transaminase (ALT)) ... ≤ 5 x ULN if transaminase elevation is attributable to liver metastases",
                    "criterion": "serum transaminase (AST or ALT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "x ULN"
                            }
                        },
                        {
                            "requirement_type": "transaminase elevation attributable to liver metastases",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate bone marrow function (within 1 week prior to first administration): Neutrophils≥1.5 x10*9 cells/L (Criteria must be met without the use of Granulocyte-Colony Stimulating Factor (G-CSF) within last week prior to testing.); platelet count≥75 x10*9 cells/L; Hb ≥9g/dL (Criteria must be met without packed red blood cell (pRBC) transfusion within last week prior to testing.)",
            "criterions": [
                {
                    "exact_snippets": "Neutrophils≥1.5 x10*9 cells/L (Criteria must be met without the use of Granulocyte-Colony Stimulating Factor (G-CSF) within last week prior to testing.)",
                    "criterion": "neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "x10^9 cells/L"
                            }
                        },
                        {
                            "requirement_type": "G-CSF use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "platelet count≥75 x10*9 cells/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 75,
                                "unit": "x10^9 cells/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Hb ≥9g/dL (Criteria must be met without packed red blood cell (pRBC) transfusion within last week prior to testing.)",
                    "criterion": "hemoglobin (Hb) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        },
                        {
                            "requirement_type": "pRBC transfusion",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)",
            "criterions": [
                {
                    "exact_snippets": "Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)",
                    "criterion": "HER2 mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)",
                    "criterion": "EGFR exon 20 insertion",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)",
                    "criterion": "HER2 amplification",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Documented HER2 or EGFR mutation (HER2 mutation or EGFR exon 20 insertion, HER2 amplification or overexpression)",
                    "criterion": "HER2 overexpression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "3. other malignancy with no known active disease present and no treatment administered during the last 2 years",
            "criterions": [
                {
                    "exact_snippets": "other malignancy with no known active disease present",
                    "criterion": "other malignancy",
                    "requirements": [
                        {
                            "requirement_type": "disease activity",
                            "expected_value": "no known active disease present"
                        }
                    ]
                },
                {
                    "exact_snippets": "no treatment administered during the last 2 years",
                    "criterion": "other malignancy treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment administration",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time period",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgery within 4 weeks prior to the first dose of study treatment",
            "criterions": [
                {
                    "exact_snippets": "Major surgery within 4 weeks prior to the first dose of study treatment",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled spinal cord compression",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled spinal cord compression",
                    "criterion": "spinal cord compression",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient with symptomatic or progressive brain metastases",
            "criterions": [
                {
                    "exact_snippets": "symptomatic or progressive brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "progressive",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of a second primary cancer with the exception of",
            "criterions": [
                {
                    "exact_snippets": "History of a second primary cancer",
                    "criterion": "second primary cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. curatively treated cervical or breast carcinoma in situ, or",
            "criterions": [
                {
                    "exact_snippets": "curatively treated cervical ... carcinoma in situ",
                    "criterion": "cervical carcinoma in situ",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "curatively treated"
                        }
                    ]
                },
                {
                    "exact_snippets": "curatively treated ... breast carcinoma in situ",
                    "criterion": "breast carcinoma in situ",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "curatively treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. curatively treated non-melanomatous skin cancer,",
            "criterions": [
                {
                    "exact_snippets": "curatively treated non-melanomatous skin cancer",
                    "criterion": "non-melanomatous skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "curatively treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any severe concurrent disease or condition (includes active infections, cardiac arrhythmia) that in the judgment of the Investigator would make study participation inappropriate for the patient",
            "criterions": [
                {
                    "exact_snippets": "Any severe concurrent disease or condition",
                    "criterion": "severe concurrent disease or condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                },
                {
                    "exact_snippets": "active infections",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known or suspected leptomeningeal disease (LMD)",
            "criterions": [
                {
                    "exact_snippets": "Known or suspected leptomeningeal disease (LMD)",
                    "criterion": "leptomeningeal disease (LMD)",
                    "requirements": [
                        {
                            "requirement_type": "presence or suspicion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of acute coronary syndromes, including myocardial infarction, coronary artery bypass graft, unstable angina, coronary angioplasty or stenting within past 24 weeks",
            "criterions": [
                {
                    "exact_snippets": "History of acute coronary syndromes, including myocardial infarction, coronary artery bypass graft, unstable angina, coronary angioplasty or stenting within past 24 weeks",
                    "criterion": "acute coronary syndromes",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "myocardial infarction ... within past 24 weeks",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary artery bypass graft ... within past 24 weeks",
                    "criterion": "coronary artery bypass graft",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina ... within past 24 weeks",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary angioplasty or stenting within past 24 weeks",
                    "criterion": "coronary angioplasty or stenting",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 24,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of or current Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system",
            "criterions": [
                {
                    "exact_snippets": "History of or current Class II, III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system",
                    "criterion": "heart failure (NYHA Class II, III, or IV)",
                    "requirements": [
                        {
                            "requirement_type": "history or current presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "NYHA class",
                            "expected_value": [
                                "II",
                                "III",
                                "IV"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Infection with human immunodeficiency virus (HIV) or prior hepatitis B or active chronic hepatitis B or active hepatitis C",
            "criterions": [
                {
                    "exact_snippets": "Infection with human immunodeficiency virus (HIV)",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior hepatitis B",
                    "criterion": "prior hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active chronic hepatitis B",
                    "criterion": "active chronic hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": "chronic"
                        }
                    ]
                },
                {
                    "exact_snippets": "active hepatitis C",
                    "criterion": "active hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of (non-infectious) interstitial lung disease (ILD) or pneumonitis that required steroids, or any evidence of current ILD or pneumonitis",
            "criterions": [
                {
                    "exact_snippets": "History of (non-infectious) interstitial lung disease (ILD) ... that required steroids",
                    "criterion": "interstitial lung disease (ILD)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "infectious status",
                            "expected_value": "non-infectious"
                        },
                        {
                            "requirement_type": "treatment required",
                            "expected_value": "steroids"
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... pneumonitis that required steroids",
                    "criterion": "pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment required",
                            "expected_value": "steroids"
                        }
                    ]
                },
                {
                    "exact_snippets": "any evidence of current ILD",
                    "criterion": "interstitial lung disease (ILD)",
                    "requirements": [
                        {
                            "requirement_type": "current evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any evidence of current ... pneumonitis",
                    "criterion": "pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "current evidence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Medical, psychiatric, cognitive or other conditions that compromise the patients ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study",
            "criterions": [
                {
                    "exact_snippets": "Medical, psychiatric, cognitive or other conditions that compromise the patients ability to understand the patient information",
                    "criterion": "ability to understand patient information",
                    "requirements": [
                        {
                            "requirement_type": "compromised_by_condition",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive or other conditions that compromise the patients ability ... to give informed consent",
                    "criterion": "ability to give informed consent",
                    "requirements": [
                        {
                            "requirement_type": "compromised_by_condition",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive or other conditions that compromise the patients ability ... to comply with the study protocol",
                    "criterion": "ability to comply with the study protocol",
                    "requirements": [
                        {
                            "requirement_type": "compromised_by_condition",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Medical, psychiatric, cognitive or other conditions that compromise the patients ability ... to complete the study",
                    "criterion": "ability to complete the study",
                    "requirements": [
                        {
                            "requirement_type": "compromised_by_condition",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}